1. Home
  2. ROIV vs BRBR Comparison

ROIV vs BRBR Comparison

Compare ROIV & BRBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROIV
  • BRBR
  • Stock Information
  • Founded
  • ROIV 2014
  • BRBR 2019
  • Country
  • ROIV United Kingdom
  • BRBR United States
  • Employees
  • ROIV N/A
  • BRBR N/A
  • Industry
  • ROIV Biotechnology: Pharmaceutical Preparations
  • BRBR Packaged Foods
  • Sector
  • ROIV Health Care
  • BRBR Consumer Staples
  • Exchange
  • ROIV Nasdaq
  • BRBR Nasdaq
  • Market Cap
  • ROIV 8.4B
  • BRBR 8.8B
  • IPO Year
  • ROIV N/A
  • BRBR 2019
  • Fundamental
  • Price
  • ROIV $10.64
  • BRBR $60.75
  • Analyst Decision
  • ROIV Buy
  • BRBR Buy
  • Analyst Count
  • ROIV 4
  • BRBR 18
  • Target Price
  • ROIV $17.50
  • BRBR $77.56
  • AVG Volume (30 Days)
  • ROIV 6.2M
  • BRBR 2.0M
  • Earning Date
  • ROIV 05-29-2025
  • BRBR 05-05-2025
  • Dividend Yield
  • ROIV N/A
  • BRBR N/A
  • EPS Growth
  • ROIV N/A
  • BRBR 49.75
  • EPS
  • ROIV N/A
  • BRBR 2.14
  • Revenue
  • ROIV $122,585,000.00
  • BRBR $2,192,100,000.00
  • Revenue This Year
  • ROIV N/A
  • BRBR $18.32
  • Revenue Next Year
  • ROIV N/A
  • BRBR $10.97
  • P/E Ratio
  • ROIV N/A
  • BRBR $28.54
  • Revenue Growth
  • ROIV 140.04
  • BRBR 18.91
  • 52 Week Low
  • ROIV $8.73
  • BRBR $48.06
  • 52 Week High
  • ROIV $13.06
  • BRBR $80.67
  • Technical
  • Relative Strength Index (RSI)
  • ROIV 47.30
  • BRBR 27.88
  • Support Level
  • ROIV $11.02
  • BRBR $60.16
  • Resistance Level
  • ROIV $11.77
  • BRBR $79.57
  • Average True Range (ATR)
  • ROIV 0.33
  • BRBR 2.85
  • MACD
  • ROIV -0.02
  • BRBR -1.86
  • Stochastic Oscillator
  • ROIV 28.93
  • BRBR 3.04

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About BRBR BellRing Brands Inc.

BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders and nutrition bars. The company's products are distributed through a diverse network of channels including club, food, drug and mass, eCommerce, convenience and specialty.

Share on Social Networks: